These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11378241)

  • 21. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.
    Baranello RJ; Bharani KL; Padmaraju V; Chopra N; Lahiri DK; Greig NH; Pappolla MA; Sambamurti K
    Curr Alzheimer Res; 2015; 12(1):32-46. PubMed ID: 25523424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
    Flood DG; Reaume AG; Dorfman KS; Lin YG; Lang DM; Trusko SP; Savage MJ; Annaert WG; De Strooper B; Siman R; Scott RW
    Neurobiol Aging; 2002; 23(3):335-48. PubMed ID: 11959395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease.
    Hellström-Lindahl E; Viitanen M; Marutle A
    Neurochem Int; 2009 Sep; 55(4):243-52. PubMed ID: 19524115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.
    Sodeyama N; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):548-51. PubMed ID: 9576554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene.
    Ishii K; Ii K; Hasegawa T; Shoji S; Doi A; Mori H
    Neurosci Lett; 1997 May; 228(1):17-20. PubMed ID: 9197277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain.
    Tamaoka A; Odaka A; Ishibashi Y; Usami M; Sahara N; Suzuki N; Nukina N; Mizusawa H; Shoji S; Kanazawa I
    J Biol Chem; 1994 Dec; 269(52):32721-4. PubMed ID: 7806491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.
    Kumar-Singh S; Cras P; Wang R; Kros JM; van Swieten J; Lübke U; Ceuterick C; Serneels S; Vennekens K; Timmermans JP; Van Marck E; Martin JJ; van Duijn CM; Van Broeckhoven C
    Am J Pathol; 2002 Aug; 161(2):507-20. PubMed ID: 12163376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abeta42, presenilins, and Alzheimer's disease.
    Iwatsubo T
    Neurobiol Aging; 1998; 19(1 Suppl):S11-3. PubMed ID: 9562460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
    Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
    Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations.
    Lleó A; Berezovska O; Growdon JH; Hyman BT
    Am J Geriatr Psychiatry; 2004; 12(2):146-56. PubMed ID: 15010344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.
    Horsburgh K; Cole GM; Yang F; Savage MJ; Greenberg BD; Gentleman SM; Graham DI; Nicoll JA
    Neuropathol Appl Neurobiol; 2000 Apr; 26(2):124-32. PubMed ID: 10840275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent advances in the studies on Alzheimer's diseases].
    Tsuji S
    Rinsho Shinkeigaku; 1998 Dec; 38(12):983-7. PubMed ID: 10349334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38.
    Moro ML; Giaccone G; Lombardi R; Indaco A; Uggetti A; Morbin M; Saccucci S; Di Fede G; Catania M; Walsh DM; Demarchi A; Rozemuller A; Bogdanovic N; Bugiani O; Ghetti B; Tagliavini F
    Acta Neuropathol; 2012 Dec; 124(6):809-21. PubMed ID: 23143229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characterization of amyloid beta protein species in the plasma, cerebrospinal fluid and brains of patients with Alzheimer's disease].
    Tamaoka A
    Nihon Ronen Igakkai Zasshi; 1998 Apr; 35(4):273-7. PubMed ID: 9643008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).
    Mann DM; Iwatsubo T; Cairns NJ; Lantos PL; Nochlin D; Sumi SM; Bird TD; Poorkaj P; Hardy J; Hutton M; Prihar G; Crook R; Rossor MN; Haltia M
    Ann Neurol; 1996 Aug; 40(2):149-56. PubMed ID: 8773595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.